Advanced Biological Laboratories (ABL) has acquired all the assets of Evivar Medical (Evivar), which includes its Hepatitis B virus (HBV) and C (HCV) web-based decision support tools and the associated viral genome analysis systems (SeqHepB ...
Advanced Biological Laboratories (ABL) has received CE Mark approval to market its patient monitoring application TherapyEdge in Europe. TherapyEdge helps to not only capture but also to integrate all patient data and particular decision ...
Tags: CE Mark, Monitoring Application
Advanced Biological Laboratories (ABL) has received CE mark approval for its DeepChek and ViroScore Suite clinical genotyping solutions. The approval is based on several evaluations of the company's next generation sequencing (NGS) ...
Tags: Advanced Biological, ABL, CE mark approval, evaluations